Allworth Financial’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Allworth Financial’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-750	Closed	-$2.72K	–	3864
2024 Q2	$2.72K	Hold	750	–	–	﹤0.01%	2787
2024 Q1	$3.24K	Hold	750	–	–	﹤0.01%	2600
2023 Q4	$2.29K	Hold	750	–	–	﹤0.01%	2624
2023 Q3	$1.08K	Hold	750	–	–	﹤0.01%	2823
2023 Q2	$1.87K	Hold	750	–	–	﹤0.01%	2514
2023 Q1	$2.01K	Hold	750	–	–	﹤0.01%	2410
2022 Q4	$4.07K	Hold	750	–	–	﹤0.01%	1978
2022 Q3	$9K	Hold	750	–	–	﹤0.01%	1722
2022 Q2	$4K	Hold	750	–	–	﹤0.01%	1855
2022 Q1	$6K	Sell	750 -512	-41%	-$4.86K	﹤0.01%	1612
2021 Q4	$13K	Hold	1,262	–	–	﹤0.01%	1307
2021 Q3	$17K	Buy	+1,262	New	+$20.6K	﹤0.01%	1096

Allworth Financial's GTHX Position: Q3 2024 in Review

Allworth Financial sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 750 shares — an estimated $2.72K sold.

Allworth Financial first reported a position in GTHX in Q3 2021 and held it in 12 quarters. The position peaked at $17K in Q3 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

Allworth Financial reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Allworth Financial sold 750 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $2.72K.
Allworth Financial first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2021 and held it in 12 quarters.
Allworth Financial's G1 Therapeutics, Inc. Common Stock position peaked at $17K in Q3 2021.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Allworth Financial's 13F filing for Q3 2024, filed 23 Oct 2024.